NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health & Medicine Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health & Medicine Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Antineuronal Antibodies



Anti-Ma2 antibody may occur in breast cancer expressing Ma1, Ma2, and Ma3



October 27th, 2003

Antineuronal antibodies versus Ma2 antigen may occur in atypical breast cancer patients, even if the cancer also expresses Ma1 and Ma3; the reaction appears to depend on the host.

"A 69-year-old woman presented with cognitive impairment and supranuclear gaze palsy caused by paraneoplastic limbic/brain stem encephalitis associated with atypical medullary breast carcinoma," scientists in Japan report.

"The cerebrospinal fluid from the patient harbored an anti-neuronal cell antibody against Ma2 antigen, but not against Ma1 or Ma3 antigen. Despite the antibody being restricted to the Ma2 antigen, the patient's cancer tissue expressed Ma1, Ma2, and Ma3...


Source: Health & Medicine Week (2003-10-27)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login